Ligation Device Market Size to Surpass USD 3.71 Billion by 2035 Driven by Minimally Invasive Surgery Growth

The global ligation device market size is projected to reach USD 3.71 billion by 2035, up from USD 1.84 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.26% from 2026 to 2035. Key drivers include the surge in minimally invasive surgeries (MIS) and the increasing demand for surgical procedures that require precise blood vessel and tissue ligation. As healthcare providers prioritize enhanced recovery and reduced patient trauma, ligation devices are becoming integral to modern surgical practices.

Where Data Meets Strategic Clarity 📥 View Sample Pages of the Complete Report 👉 https://www.precedenceresearch.com/sample/8210

Market Size and Forecasts

🔹 Market size in 2025: USD 1.84 Billion
🔹 Market size in 2026: USD 1.97 Billion
🔹 Market size by 2035: USD 3.71 Billion
🔹 CAGR: 7.26% (2026-2035)
🔹 Forecast period: 2026-2035
🔹 Base year: 2025

The Role of AI in Ligation Devices:

AI technology is transforming ligation devices, offering advanced features like real-time surgical guidance, robotic-assisted autonomy, and enhanced safety measures. AI systems analyze video feeds, guide surgeons in identifying key anatomical structures, and ensure accurate ligation, minimizing human error during complex procedures. As these technologies evolve, their ability to enhance the precision and safety of surgeries will drive further adoption of ligation devices in medical facilities worldwide.

🔗 What's Fueling the Next Wave of Growth? 👉 https://www.precedenceresearch.com/ligation-device-market

Market Growth Factors:

• Minimally Invasive Surgeries (MIS) Surge: A significant market growth driver is the rising preference for MIS due to its advantages such as faster recovery times, less trauma, and lower infection rates.

• Technological Advancements: Ligation devices are incorporating AI and robotic systems that improve their accuracy and efficiency, reducing the complexity and risk of surgeries.

• Rising Surgical Volume: An increase in surgeries, particularly in gastrointestinal, gynecological, and urological fields, is expected to boost demand for ligation devices.

• Increasing Disposable Device Usage: Single-use ligation accessories are gaining popularity due to their hygiene and safety advantages, contributing to market growth.

➡️ Become a valued research partner with us https://www.precedenceresearch.com/schedule-meeting

Opportunities & Trends in the Market

The market offers substantial growth potential through the expansion of minimally invasive surgeries, technological integration, and the growing preference for disposable accessories in healthcare settings. Additionally, emerging markets in Asia Pacific provide significant untapped opportunities.

Trends include a rise in robotic-assisted surgeries, the integration of AI for surgical precision, and an increasing focus on patient recovery through less invasive techniques.

🔓 Instant Access. Zero Waiting. 📥 Buy the Premium Market Research Report Now 👉 https://www.precedenceresearch.com/checkout/8210

Ligation Device Market Regional Analysis

North America dominated the ligation device market in 2025, with a size of USD 809.60 million, expected to reach USD 1,650.95 million by 2035 at a CAGR of 7.39%. Growth is driven by advanced healthcare infrastructure, the adoption of minimally invasive surgeries, and a high prevalence of chronic health conditions.

The U.S. specifically contributed USD 607.20 million in 2025, projected to reach USD 1,246.47 million by 2035 (CAGR 6.52%). The growth is supported by advanced surgical facilities and the increasing number of ambulatory surgical centers.

The Asia Pacific region is expected to experience the fastest growth, driven by rising medical expenditures, improving healthcare infrastructure, and growing demand for surgical procedures. China, in particular, will contribute significantly due to its aging population and increased investments in advanced surgical research and training.

Note: This report is readily available for immediate delivery. We can review it with you in a meeting to ensure data reliability and quality for decision-making.

Try Before You Buy - Get the Sample Report@ https://www.precedenceresearch.com/sample/8210

Ligation Device Market Segment Analysis

🔹 Application Analysis

The gastrointestinal and abdominal surgery segment dominated the ligation device market in 2025, driven by the rising prevalence of gastrointestinal disorders and the growing geriatric population. Ligation devices help manage tissue effectively during these surgeries, supporting minimally invasive procedures like endoscopic clip applications.

The cardiothoracic segment is expected to grow the fastest, fueled by the increasing incidence of cardiovascular diseases such as aneurysms and arrhythmias. Demand for procedures like CABG and valve replacements, along with minimally invasive cardiac surgeries, is driving growth.

🔹 Procedure Type Analysis

In 2025, minimally invasive surgery (MIS) accounted for 81% of the market share, due to its ability to reduce patient trauma, shorten recovery times, and enhance surgical precision. Devices like endoscopic clip appliers and vascular sealing instruments have become essential in these procedures.

The open surgery segment, while smaller at 19%, is expected to grow significantly between 2026 and 2035. This growth is driven by the rising prevalence of cardiovascular disorders and emergency procedures requiring reusable ligation devices for quick, effective outcomes.

🔹 End-Use Analysis

Hospitals led the market in 2025 with 72% share, as they perform a wide range of surgical procedures and invest heavily in advanced surgical technologies. The demand for both disposable and reusable vessel sealing tools supports this dominance.

Ambulatory surgical centers (ASCs) are projected to grow rapidly due to the rising popularity of outpatient procedures, cost-effectiveness, and shorter recovery times. Stricter infection control regulations and the use of disposable accessories also boost this segment.

Ligation Device Market Companies and Their Offerings

➢ Medtronic
↳ Lapro‐ClipTM Ligation System: reusable clip applier delivering single‐use absorbable ligating clips (8-12 mm) for laparoscopic and open surgery; designed for long‐term vessel healing (up to ~180 days) and secure 360°‐angle placement.
↳ LigaSureTM vessel‐sealing platforms: bipolar‐sealing devices (e.g., LigaSure Exact, XP Maryland, curved jaw) used for thermal ligation and division of vessels up to ~7 mm in open and minimally invasive procedures.

➢ Johnson & Johnson (MedTech)
↳ Primarily competes via vessel‐sealing and energy‐based devices such as bipolar and ultrasonic vessel‐sealing systems (e.g., Ethicon Echelon / Endo GIA platforms with integrated sealing jaws) that thermally ligate and divide tissue bundles and vessels up to about 7 mm in general, gynecologic, thoracic, and bariatric surgery.
↳ Traditional metal and polymer ligation clips are available under Ethicon/J&J surgical brands but are now often positioned as adjuncts to its primary energy‐based ligation and stapling platforms.

➢ The Cooper Companies, Inc. (CooperSurgical)
↳ INSORB® absorbable ligating clips: bioabsorbable clips used in laparoscopic and open procedures for temporary vessel/duct ligation, gradually absorbed over months.
↳ Surgical ligature needles (e.g., Cooper‐branded ligature needles) for manual suture‐based ligation in vascular and soft‐tissue procedures.

➢ CONMED Corporation
↳ CleanSeal Vessel Sealers: bipolar electrosurgical sealer/dividers that provide thermal ligation and cutting of vessels up to 7 mm in open and minimally invasive gynecologic and general‐surgery procedures.
↳ These devices are positioned as energy‐based ligation tools rather than clip‐based, covering similar indications as LigaSure and other vessel‐sealing platforms.

➢ B. Braun SE (Aesculap)
↳ Titanium ligating clips and Aesculap ligation‐clip systems: reusable/metal‐clip platforms for open and laparoscopic procedures, offering permanent vessel occlusion (titanium clips remain in situ)
↳ Appendectomy‐specific clips (e.g., DS Appendectomy‐Clip) and related clip‐applier systems for routine ligation of the appendix and other vessels in GI and general surgery.

➢ Teleflex Inc.
↳ Hem‐o‐lok® polymer locking ligation system: clips and reloads for open and laparoscopic ligation, emphasizing "cool ligation" (minimal thermal spread) with secure locking and re‐positionability.
↳ HorizonTM and Hemoclip metal ligation systems: traditional metal clips for cardiovascular and general‐surgery applications, including a range of sizes for different vessel diameters.

➢ Olympus Corporation
↳ PolyLoopTM Loop Ligation Device: single‐use, pre‐assembled endoscopic loop device for endoscopic polypectomy ligation, designed to snare and ligate small and large polyps while minimizing sudden bleeding during polypectomy
↳ Primarily positioned in GI endoscopy, not open or laparoscopic surgery, but directly relevant to the broader ligation device ecosystem.

➢ Smith & Nephew plc
↳ Core focus is sports‐medicine and orthopedic fixation (e.g., ULTRABUTTON adjustable fixation devices for tendon‐graft and ligament fixation), which are mechanical fixation rather than vascular ligation.
↳ No major branded vascular ligation clips or vessel‐sealing devices; its surgical portfolio emphasizes soft‐tissue and orthopedic fixation, not general‐surgical ligation or hemostasis tools.

➢ Applied Medical
↳ Known for advanced laparoscopic instrumentation (e.g., Epix line of reusable‐handle/disposable‐cartridge graspers) that support tissue manipulation and, indirectly, ligation by enabling precise vessel control prior to clip or suture application.
↳ Does not market a dedicated, branded ligation clip or energy‐based sealing platform; its role in the ligation market is largely as an enabling laparoscopic‐instrument supplier rather than a direct ligation‐device vendor.

➢ Stryker Corporation
↳ Reprocessed/Remanufactured Covidien LigaSureTM Sealer/Divider: Stryker‐branded reprocessed versions of Medtronic‐origin LigaSure bipolar vessel‐sealing devices, used for ligation and division of vessels up to 7 mm in general, urologic, gynecologic, thoracic, and vascular procedures.
↳ Focus is on reprocessed LigaSure instruments, giving Stryker a presence in the ligation device market via remanufactured, lower‐cost versions of the same energy‐based sealing‐and‐ligation platforms.

Recent Advancements

🔸 Olympus Corporation announced a voluntary corrective action for its PolyLoop ligating device in December 2025 due to a safety issue identified during use. The device is designed for controlling bleeding during polypectomy procedures.

🔸 Asensus Surgical received FDA approval for its Senhance Surgical System in July 2024, enabling its use in urological procedures. This digital laparoscopic system enhances surgical precision through real-time feedback and robotic assistance.

Segments Covered in the Report

🔹 By Application

Gastrointestinal and Abdominal Surgery
Gynecological Surgery
Cardiothoracic Surgery
Urological Surgery
Bariatric
Vascular
Other

🔹 By Procedure Type

MIS
Open surgery

🔹 By End-Use

Hospitals
Ambulatory Surgical Centers

🔹 By Region

North America
Latin America
Europe
Asia-pacific
Middle and East Africa

The ligation device market is poised for continued growth, with key drivers such as advancements in AI-driven surgical technologies, increased demand for minimally invasive surgeries, and expanding applications in various specialties. The integration of digital health tools, coupled with growing investments in healthcare infrastructure, presents promising opportunities for market players.

As new applications emerge in bariatric and endoscopic procedures, ligation devices are expected to play an even more significant role in reshaping surgical approaches. The ongoing shift toward outpatient procedures and increased adoption of disposable devices further reinforces the market's growth trajectory.

The ligation device market is on a strong growth path, driven by advancements in surgical technologies, rising demand for minimally invasive procedures, and an expanding patient pool requiring surgical interventions. As the market grows, innovative solutions and expanding applications will create new opportunities for stakeholders across the healthcare sector. Now is the time for industry players to capitalize on these trends and solidify their positions in this rapidly evolving market.

Connect With Us

📞 USA: +1 804 441 9344
📞 APAC: +61 485 981 310 or +91 87933 22019 | +6531051271
📞 Europe: +44 7383 092 044
📩 Email: sales@precedenceresearch.com

Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.

🌐 Web: https://www.precedenceresearch.com

Our Trusted Data Partners:
🔹https://www.towardshealthcare.com
🔹https://www.towardspackaging.com
🔹https://www.towardschemandmaterials.com
🔹https://www.towardsfnb.com
🔹https://www.marketstatsinsight.com

Get Recent News:
https://www.precedenceresearch.com/news

For the Latest Update, Follow Us:
🔹https://www.linkedin.com/company/precedence-research
🔹https://x.com/Precedence_R
🔹https://www.facebook.com/precedenceresearch
🔹https://precedence-research.medium.com/

This release was published on openPR.